HELIX BIOPHARMA CORP (HBP.CA) Stock Price, Quote, News and Overview
TSX:HBP - Toronto Stock Exchange - CA4229102088 - Common Stock - Currency: CAD
HBP.CA Quote, Performance and Key Statistics
TSX:HBP (6/23/2025, 7:00:00 PM)
0.93
+0.03 (+3.33%)
The current stock price of HBP.CA is 0.93 CAD. In the past month the price decreased by -3.12%. In the past year, price decreased by -11.43%.
HBP.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 297.47M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 233.80M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 212.23M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 155.87M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 76.39M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 68.05M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 18.31 | 65.26M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 59.60M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 58.20M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 43.27M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 30 | 42.24M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 28.97M |
Related stock screener links
About HBP.CA
Company Profile
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. The company is headquartered in Toronto, Ontario and currently employs 7 full-time employees. The firm is focused on developing therapies in the field of immune oncology for the prevention and treatment of cancer based on its proprietary technological platform DOS47. DOS47 is a broad anti-cancer antibody drug conjugate (ADC) platform. DOS47 is based upon a naturally occurring enzyme isolated from the jack bean plant called urease that breaks down a natural substance found in the body, urea, into metabolites that include ammonium and hydroxyl ions. By doing so at the site of cancerous tissues in the body, DOS47 is designed to stimulate an increase in the pH of the microenvironment surrounding the cancerous cells, effectively reversing the acidic extracellular conditions that are believed to act to defend the tumor. Its pipeline includes L-DOS47 monotherapy NSCLC, L-DOS47 combo PEM/CARBO NSCLC, L-DOS47 DOXO combo Pancreas, and L-DOS47 combo Immune Checkpoints.
Company Info
HELIX BIOPHARMA CORP
Bay Adelaide Centre - North Tower 40, Temperance Street, Suite 2700 Toronto
TORONTO ONTARIO L4B 3J9 CA
CEO: Heman Chao
Employees: 7
Phone: 16046842181
HELIX BIOPHARMA CORP / HBP.CA FAQ
What is the stock price of HELIX BIOPHARMA CORP today?
The current stock price of HBP.CA is 0.93 CAD. The price increased by 3.33% in the last trading session.
What is the ticker symbol for HELIX BIOPHARMA CORP stock?
The exchange symbol of HELIX BIOPHARMA CORP is HBP and it is listed on the Toronto Stock Exchange exchange.
On which exchange is HBP.CA stock listed?
HBP.CA stock is listed on the Toronto Stock Exchange exchange.
What is HELIX BIOPHARMA CORP worth?
HELIX BIOPHARMA CORP (HBP.CA) has a market capitalization of 49.31M CAD. This makes HBP.CA a Nano Cap stock.
How many employees does HELIX BIOPHARMA CORP have?
HELIX BIOPHARMA CORP (HBP.CA) currently has 7 employees.
What are the support and resistance levels for HELIX BIOPHARMA CORP (HBP.CA) stock?
HELIX BIOPHARMA CORP (HBP.CA) has a support level at 0.92 and a resistance level at 0.94. Check the full technical report for a detailed analysis of HBP.CA support and resistance levels.
Should I buy HELIX BIOPHARMA CORP (HBP.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HBP.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HBP.CA, evaluating the profitability, health, valuation and growth aspects
- HELIX BIOPHARMA CORP (HBP.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HELIX BIOPHARMA CORP (HBP.CA) Sales and EPS estimates to see what analysts future expectations are.
- HELIX BIOPHARMA CORP (HBP.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HELIX BIOPHARMA CORP (HBP.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- HELIX BIOPHARMA CORP (HBP.CA) Stock Chart to make your own analysis
- HELIX BIOPHARMA CORP (HBP.CA) Latest news and press-releases to stay up to date.
Does HELIX BIOPHARMA CORP (HBP.CA) stock pay dividends?
HBP.CA does not pay a dividend.
When does HELIX BIOPHARMA CORP (HBP.CA) report earnings?
HELIX BIOPHARMA CORP (HBP.CA) will report earnings on 2025-10-22.
What is the Price/Earnings (PE) ratio of HELIX BIOPHARMA CORP (HBP.CA)?
HELIX BIOPHARMA CORP (HBP.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
HBP.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to HBP.CA. When comparing the yearly performance of all stocks, HBP.CA is a bad performer in the overall market: 79.41% of all stocks are doing better.
HBP.CA Financial Highlights
Over the last trailing twelve months HBP.CA reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -76.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -944.8% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HBP.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to HBP.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.